(3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol

C112H163N25O10 — CID 158632147

About (3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol

(3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol (PubChem CID 158632147) has the molecular formula C112H163N25O10 and a molecular weight of 2019.70 g/mol. Its IUPAC name is (3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol.

Molecular Properties

• Compound Name: (3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol
• PubChem CID: 158632147
• Molecular Formula: C112H163N25O10
• Molecular Weight: 2019.70 g/mol
• Exact Mass: 2018.30
• IUPAC Name: (3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol
• SMILES: COC1CN(c2nc3c(cc2-c2nc(C)no2)CCCC3)CCC1NC1CCCCC1.Cc1cnc(N2CCC(NC3CCCCC3)C(C)C2)c(-c2nc(C)no2)c1.Cc1cnc(N2CCC(NC3CCOCC3)C(CO)C2)c(-c2nc(C)no2)c1.Cc1noc(-c2cc3c(nc2N2CCC(NC4CCCCC4)C(CO)C2)CCCC3)n1.Cc1noc(-c2cc3c(nc2N2CC[C@@H](NC4CCCCC4)[C@H](O)C2)CCCC3)n1
• InChI: InChI=1S/2C24H35N5O2.C23H33N5O2.C21H31N5O.C20H29N5O3/c1-16-25-24(31-28-16)19-14-17-8-6-7-11-20(17)27-23(19)29-13-12-21(22(15-29)30-2)26-18-9-4-3-5-10-18;1-16-25-24(31-28-16)20-13-17-7-5-6-10-21(17)27-23(20)29-12-11-22(18(14-29)15-30)26-19-8-3-2-4-9-19;1-15-24-23(30-27-15)18-13-16-7-5-6-10-19(16)26-22(18)28-12-11-20(21(29)14-28)25-17-8-3-2-4-9-17;1-14-11-18(21-23-16(3)25-27-21)20(22-12-14)26-10-9-19(15(2)13-26)24-17-7-5-4-6-8-17;1-13-9-17(20-22-14(2)24-28-20)19(21-10-13)25-6-3-18(15(11-25)12-26)23-16-4-7-27-8-5-16/h14,18,21-22,26H,3-13,15H2,1-2H3;13,18-19,22,26,30H,2-12,14-15H2,1H3;13,17,20-21,25,29H,2-12,14H2,1H3;11-12,15,17,19,24H,4-10,13H2,1-3H3;9-10,15-16,18,23,26H,3-8,11-12H2,1-2H3/t;;20-,21-;;/m..1../s1
• InChIKey: HZIDZUKQPNPINT-HSTOWFECSA-N
• XLogP: 16.03
• TPSA: 414.55 Ų
• H-Bond Donors: 8
• H-Bond Acceptors: 35
• Rotatable Bonds: 23
• Heavy Atoms: 147
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2019.70
LogP ≤ 5	16.03
H-Bond Donors ≤ 5	8
H-Bond Acceptors ≤ 10	35

Frequently Asked Questions

What is the IUPAC name of (3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol?

The IUPAC name of (3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol (CID 158632147) is (3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol.

What is the SMILES notation for (3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol?

The canonical SMILES for (3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol is COC1CN(c2nc3c(cc2-c2nc(C)no2)CCCC3)CCC1NC1CCCCC1.Cc1cnc(N2CCC(NC3CCCCC3)C(C)C2)c(-c2nc(C)no2)c1.Cc1cnc(N2CCC(NC3CCOCC3)C(CO)C2)c(-c2nc(C)no2)c1.Cc1noc(-c2cc3c(nc2N2CCC(NC4CCCCC4)C(CO)C2)CCCC3)n1.Cc1noc(-c2cc3c(nc2N2CC[C@@H](NC4CCCCC4)[C@H](O)C2)CCCC3)n1.

What is the InChIKey of (3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol?

The InChIKey is HZIDZUKQPNPINT-HSTOWFECSA-N. The full InChI is InChI=1S/2C24H35N5O2.C23H33N5O2.C21H31N5O.C20H29N5O3/c1-16-25-24(31-28-16)19-14-17-8-6-7-11-20(17)27-23(19)29-13-12-21(22(15-29)30-2)26-18-9-4-3-5-10-18;1-16-25-24(31-28-16)20-13-17-7-5-6-10-21(17)27-23(20)29-12-11-22(18(14-29)15-30)26-19-8-3-2-4-9-19;1-15-24-23(30-27-15)18-13-16-7-5-6-10-19(16)26-22(18)28-12-11-20(21(29)14-28)25-17-8-3-2-4-9-17;1-14-11-18(21-23-16(3)25-27-21)20(22-12-14)26-10-9-19(15(2)13-26)24-17-7-5-4-6-8-17;1-13-9-17(20-22-14(2)24-28-20)19(21-10-13)25-6-3-18(15(11-25)12-26)23-16-4-7-27-8-5-16/h14,18,21-22,26H,3-13,15H2,1-2H3;13,18-19,22,26,30H,2-12,14-15H2,1H3;13,17,20-21,25,29H,2-12,14H2,1H3;11-12,15,17,19,24H,4-10,13H2,1-3H3;9-10,15-16,18,23,26H,3-8,11-12H2,1-2H3/t;;20-,21-;;/m..1../s1.

What are the key properties of (3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol?

(3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol has a molecular weight of 2019.70 g/mol, XLogP of 16.03, 23 rotatable bonds, 8 hydrogen bond donors, and 35 hydrogen bond acceptors.

Where does this data come from?

All data for (3R,4R)-4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-ol;[4-(cyclohexylamino)-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-3-yl]methanol;N-cyclohexyl-3-methoxy-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]piperidin-4-amine;N-cyclohexyl-3-methyl-1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]piperidin-4-amine;[1-[5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-(oxan-4-ylamino)piperidin-3-yl]methanol is sourced from PubChem (CID 158632147), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).